Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Linda S. Resar"'
Autor:
Jerry L Spivak, Akil Merchant, Donna M Williams, Ophelia Rogers, Wanke Zhao, Amy Duffield, Linda S Resar, Alison R Moliterno, Zhizhuang J Zhao
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0232801 (2020)
The myeloproliferative neoplasms, polycythemia vera, essential thrombocytosis and primary myelofibrosis are hematopoietic stem cell disorders and share driver mutations that either directly activate the thrombopoietin receptor, MPL, or activate it in
Externí odkaz:
https://doaj.org/article/e50e6b55a5c045599a6aaacfc14d5345
Autor:
Wanke Zhao, Akil Merchant, Donna M. Williams, Jerry L. Spivak, Linda S. Resar, Alison R. Moliterno, Zhizhuang Joe Zhao, Ophelia Rogers, Amy S. Duffield
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 6, p e0232801 (2020)
PLoS ONE, Vol 15, Iss 6, p e0232801 (2020)
The myeloproliferative neoplasms, polycythemia vera, essential thrombocytosis and primary myelofibrosis are hematopoietic stem cell disorders and share driver mutations that either directly activate the thrombopoietin receptor, MPL, or activate it in
Autor:
Karen L. Reddy, Mikhail Gorbounov, Linda S. Resar, Briyana Chisholm, Mohammad Heydarian, Dorhyun Johng, Lingling Xian, Guangjing Zhu, Lionel Chia, William B. Isaacs
Publikováno v:
Cancer Research. 79:2595-2595
While High Mobility Group A1 (HMGA1) chromatin remodeling proteins are frequently dysregulated in diverse cancers, their molecular underpinnings in carcinogenesis remain poorly understood. HMGA1 are small, non-histone proteins that bind to AT-rich re
Autor:
Kirti Shetty, Chu-Xia Deng, Wilma S. Jogunoori, Richard Amdur, Linda S. Resar, Patricia Latham, Raja Mazumder, Anelia Horvath, Bao-Ngoc Nguyen, Shulin Li, Xifeng Wu, Herbert Yu, Linda L. Wong, Jon White, Sylvia Silver, Asif Rashid, Vikas Kundra, Xin Wei Wang, Lopa Mishra
Publikováno v:
Cancer Research. 79:3156-3156
In its early stages, HCC is curable; once advanced, HCC is associated with high mortality. HCC is associated with alterations in key driving pathways, including the Wnt pathway, TGF-β pathway, the p53 pathway, and pathways that regulate Myc activity
Autor:
Jon White, Chu-Xia Deng, Vikas Kundra, Xin Wei Wang, Kirti Shetty, Anelia Horvath, Patricia S. Latham, Raja Mazumder, Herbert Yu, Shuyun Rao, Wilma Jogunoori, Shulin Li, Asif Rashid, Linda S. Resar, Lopa Mishra, Linda L. Wong, Richard Amdur, Bao-Ngoc Nguyen, Sobia Zaidi
Publikováno v:
Gastroenterology. 156:S-1306
Publikováno v:
Analytical and Bioanalytical Chemistry. 405:5013-5030
Metabolomics is coming of age as an important area of investigation which may help reveal answers to questions left unanswered or only partially understood from proteomic or genomic approaches. Increased knowledge of the relationship of genes and pro
Autor:
Jacqueline Greer, Judith E. Karp, Dwella Moton-Nelson, Biju Joseph, Steven D. Gore, Hetty E. Carraway, Amanda L. Blackford, John J. Wright, Katrina Alino, Linda S. Resar, Janet Briel, Michael A. McDevitt, B. Douglas Smith, Mark J. Levis, Karen Mackey, L. Austin Doyle, Lorena Bagain, Ming Zhao, Michelle A. Rudek
Publikováno v:
Blood. 117:3302-3310
Flavopiridol is a protein bound, cytotoxic, cyclin-dependent kinase inhibitor. Flavopiridol given by 1-hour bolus at 50 mg/m2 daily 3 times followed by cytosine arabinoside and mitoxantrone (FLAM) is active in adults with poor-risk acute leukemias. A
Autor:
Linda S. Resar, William B. Issacs, Guangjing Zhu, Mohammad Heydarian, Lionel Chia, Lingling Xian, Karen L. Reddy
Publikováno v:
Cancer Research. 78:3352-3352
Increasing evidence suggests that cancer cells undergo chromatin remodeling and epigenetic reprogramming during tumor progression, although the underlying mechanisms remain poorly understood. The High Mobility Group A1 (HMGA1) chromatin binding prote
Publikováno v:
Cancer Research. 78:4494-4494
Pancreatic ductal adenocarcinomas (PDACs) are highly lethal tumors for which there are no effective therapies. Emerging evidence suggests that the tumor stroma interacts with the cancer cells to induce cancer stem cell properties and drive tumor prog
Autor:
Joelle Hillion, Mohammad Heydarian, Michael Koo, Leslie Cope, Sujayita Roy, David L. Huso, Brigitte M. Ronnett, Li Z. Luo, Karen L. Reddy, Linda S. Resar, Deborah K. Armstrong, Tait Huso, Lingling Xian, Kathleen Kellyn
Publikováno v:
Gynecologic oncology. 141(3)
Objectives Although uterine cancer is the fourth most common cause for cancer death in women worldwide, the molecular underpinnings of tumor progression remain poorly understood. The High Mobility Group A1 ( HMGA1 ) gene is overexpressed in aggressiv